Correlation Between Rakovina Therapeutics and Rogers Communications

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Rakovina Therapeutics and Rogers Communications at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rakovina Therapeutics and Rogers Communications into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rakovina Therapeutics and Rogers Communications, you can compare the effects of market volatilities on Rakovina Therapeutics and Rogers Communications and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rakovina Therapeutics with a short position of Rogers Communications. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rakovina Therapeutics and Rogers Communications.

Diversification Opportunities for Rakovina Therapeutics and Rogers Communications

-0.94
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Rakovina and Rogers is -0.94. Overlapping area represents the amount of risk that can be diversified away by holding Rakovina Therapeutics and Rogers Communications in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rogers Communications and Rakovina Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rakovina Therapeutics are associated (or correlated) with Rogers Communications. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rogers Communications has no effect on the direction of Rakovina Therapeutics i.e., Rakovina Therapeutics and Rogers Communications go up and down completely randomly.

Pair Corralation between Rakovina Therapeutics and Rogers Communications

Assuming the 90 days horizon Rakovina Therapeutics is expected to generate 5.26 times more return on investment than Rogers Communications. However, Rakovina Therapeutics is 5.26 times more volatile than Rogers Communications. It trades about 0.13 of its potential returns per unit of risk. Rogers Communications is currently generating about -0.12 per unit of risk. If you would invest  11.00  in Rakovina Therapeutics on October 31, 2024 and sell it today you would earn a total of  9.00  from holding Rakovina Therapeutics or generate 81.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Rakovina Therapeutics  vs.  Rogers Communications

 Performance 
       Timeline  
Rakovina Therapeutics 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Rakovina Therapeutics are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Rakovina Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Rogers Communications 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Rogers Communications has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Rakovina Therapeutics and Rogers Communications Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Rakovina Therapeutics and Rogers Communications

The main advantage of trading using opposite Rakovina Therapeutics and Rogers Communications positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rakovina Therapeutics position performs unexpectedly, Rogers Communications can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rogers Communications will offset losses from the drop in Rogers Communications' long position.
The idea behind Rakovina Therapeutics and Rogers Communications pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios